Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05061745 · ClinicalTrials.gov registry record · NA
Neuromodulation for Dysphoria
A NA study of Dysphoria, sponsored by Florida State University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05061745 is a NA study of Dysphoria that is actively recruiting participants, run by Florida State University. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05061745, a NA study of Dysphoria, is actively recruiting participants, sponsored by Florida State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open label prospective pilot study of two neuromodulation interventions for patients suffering from dysphoria. Dysphoria is a transdiagnostic symptom of unease or dissatisfaction experienced across a range of diagnoses, including mood disorders and pain. There is a significant gap of treatment options across conditions with dysphoria, particularly non-medicated and self-care alternatives. Many neuromodulation therapies require extensive medical resources or time to deliver. Thus, the investigators will test two non-invasive technologies administered in a manner that would reduce resources and/or time. Virtual Reality (VR) overlays the sensory system to block the external environment and provide vast range of meaningful sensory experiences. Transcranial Magnetic Stimulation (TMS) involves a magnetic pulse passing through the scalp to depolarize neurons in the outer cortex of the brain, and daily treatments over 6 weeks are currently FDA indicated for the treatment of major depressive disorder. Accelerated TMS is the delivery of treatment in a shorter period of time. The primary objective of this study to demonstrate the preliminary effectiveness, tolerability, and feasibility of these two interventions: Guided Meditation VR for Wellness and Accelerated Transcranial Magnetic Stimulation.
Conditions Studied
Interventions
- DEVICE Guided Meditation VR for Wellness
- DEVICE Accelerated Transcranial Magnetic Stimulation: Treatment A
- DEVICE Accelerated Transcranial Magnetic Stimulation: Treatment B
Study Locations (1)
Florida
- Florida State University - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2027-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05061745
The ClinicalTrials.gov registry entry for NCT05061745 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dysphoria appearing as the primary indexed condition, and to 3 interventions - of which Guided Meditation VR for Wellness is the first listed.
NCT05061745 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05061745 about?
NCT05061745 is a clinical study titled "Neuromodulation for Dysphoria". This is an open label prospective pilot study of two neuromodulation interventions for patients suffering from dysphoria. Dysphoria is a transdiagnostic symptom of unease or dissatisfaction experienced across a range of diagnoses, including mood disorders and pain. There is a significant gap of trea...
What is the current status of trial NCT05061745?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-09-29. Estimated completion is 2027-08.
What conditions does trial NCT05061745 study?
This clinical trial studies the following conditions: Dysphoria.
What interventions are being tested in trial NCT05061745?
The interventions under investigation include: Guided Meditation VR for Wellness (DEVICE), Accelerated Transcranial Magnetic Stimulation: Treatment A (DEVICE), Accelerated Transcranial Magnetic Stimulation: Treatment B (DEVICE).
Who is sponsoring clinical trial NCT05061745?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05061745 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.